Walleye Capital’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.3K Hold
200
﹤0.01% 3825
2025
Q4
$51.7K Sell
200
-1,000
-83% -$228K ﹤0.01% 4070
2025
Q3
$272K Buy
1,200
+700
+140% +$143K ﹤0.01% 3096
2025
Q2
$104K Buy
+500
New +$96.3K ﹤0.01% 3755
2025
Q1
Sell
-1,200
Closed -$271K 4799
2024
Q4
$271K Sell
1,200
-1,200
-50% -$268K ﹤0.01% 3514
2024
Q3
$500K Sell
2,400
-1,800
-43% -$362K ﹤0.01% 3301
2024
Q2
$790K Buy
+4,200
New +$779K ﹤0.01% 3078
2024
Q1
Sell
-4,900
Closed -$891K 5713
2023
Q4
$891K Sell
4,900
-1,400
-22% -$243K ﹤0.01% 2447
2023
Q3
$1.11M Buy
6,300
+6,000
+2,000% +$1.13M ﹤0.01% 2174
2023
Q2
$56.4K Buy
+300
New +$56.7K ﹤0.01% 3619
2020
Q1
Sell
-1,823
Closed -$382K 1403
2019
Q4
$382K Buy
+1,823
New +$358K 0.02% 810

Other funds holding MSGS

Walleye Capital's MSGS Position: Q1 2026 in Review

Walleye Capital reduced its Madison Square Garden (MSGS) stake by 2% in Q1 2026, selling an estimated $700K and leaving 113,285 shares worth $36.4M. The position accounts for 0.15% of the portfolio, ranked #71.

Walleye Capital first reported a position in MSGS in Q3 2018 and has held it in 13 quarters since. 408 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.

  • Walleye Capital held 113,285 shares of Madison Square Garden worth $36.4M as of Q1 2026.
  • Walleye Capital sold 2,348 Madison Square Garden shares in Q1 2026, an estimated $700K.
  • Madison Square Garden made up 0.15% of Walleye Capital's portfolio in Q1 2026, its #71 holding.
  • Walleye Capital first reported a position in Madison Square Garden in Q3 2018 and has held it in 13 quarters since.
  • 408 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.